ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 124

Ultrasound Power Doppler Findings in the Wrists and Hands Joints of Anti-CCP Antibody Positive Individuals with Non-Specific Musculoskeletal Symptoms and the Development of Inflammatory Arthritis

Jackie L. Nam, Laura Hunt, Elizabeth M.A. Hensor, Philip G. Conaghan, Richard J. Wakefield and Paul Emery, NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: anti-CCP antibodies, inflammatory arthritis, Rheumatoid arthritis (RA), risk and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Imaging of Rheumatic Diseases: Ultrasound

Session Type: Abstract Submissions (ACR)

Background/Purpose

The use of musculoskeletal ultrasound is increasing in rheumatology practice. Recently we have shown that use of power Doppler signal (PD) on ultrasound in the wrists and hands in patients who present with non-specific musculoskeletal symptoms and are anti-CCP antibody positive can aid the identification of those who will develop an inflammatory arthritis (IA). 1The aim of this study was to investigate the ultrasound findings at a joint-level in these patients and the use of PD in identifying patients who progressed to inflammatory arthritis (IA).

Methods

In a prospective observational cohort study, patients with new non-specific MSK symptoms and positive anti-CCP underwent imaging with ultrasound at baseline and were followed up for the development of IA. Patients attended for regular follow-up assessments and if necessary were seen earlier if joint symptoms changed. PD findings of the wrists, MCPs and PIPs were scored using a semi-quantitative method from 0 to3 PD using a standard method. Using multilevel binary logistic regression we modelled the association between presence of PD score>0 at baseline and presence of IA in that joint at follow-up; joints (level 1) were nested within patients (level 2).

Results

Our first 100 consecutive patients (73 females, mean age 51 years) were followed up for median 19.8 months (range 0.1-69.0); 50 developed IA after a median 7.9 months (range 0.1-52.4), 34 within 12 months. The majority who progressed to IA in at least 1 joint (43/50) fulfilled the 2010 ACR/EULAR criteria for rheumatoid arthritis. A total of 2200 joints were scanned. The majority of patients (67%) did not have any PD signal present; maximum score in any joint was 1 in 17% and 2 in 16%. None had a joint scoring 3. Progression to clinical synovitis was rare in joints scoring 0 (5% progressed) compared to joints scoring 1 (16%) or 2 (59%). The presence of positive PD signal (any score >0) in a joint at baseline was associated with a 10-fold increase in odds of the joint developing clinical swelling [OR=10.6 (5.3, 21.1), p<0.001].

Conclusion

Our findings suggest that in patients presenting with non-specific MSK symptoms and are anti-CCP antibody positive, ultrasound features of inflammation at a patient- and at a joint-level can aid the identification of patients at risk of developing IA. Results of our larger cohort will be presented.

 1. Rakieh C, Nam JL, Hunt L, Hensor EM, Das S, Bissell LA, et al. Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study. Ann. Rheum. Dis. 2014.


Disclosure:

J. L. Nam,
None;

L. Hunt,
None;

E. M. A. Hensor,
None;

P. G. Conaghan,
None;

R. J. Wakefield,
None;

P. Emery,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-power-doppler-findings-in-the-wrists-and-hands-joints-of-anti-ccp-antibody-positive-individuals-with-non-specific-musculoskeletal-symptoms-and-the-development-of-inflammatory-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology